A study of common discovery dosing formulation components and their potential for causing time-dependent matrix effects in high-performance liquid chromatography tandem mass spectrometry assays

Rapid Communications in Mass Spectrometry

Volumn 19, Issue 18, 2005, Pages 2643-2650

  Xu, Xiaoying ^a   Mei, Hong ^a   Wang, Shiyong ^a   Zhou, Qiao ^a   Wang, Ganfeng ^a   Broske, Lisa ^a   Pena, Adrienne ^a   Korfmacher, Walter A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMATOGRAPHIC ANALYSIS; DRUG PRODUCTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; HPLC-MS-MS; ION SUPPRESSION; MATRICES EFFECT; METHYL CELLULOSE; MICROMASS; PEG-400; PLASMA SAMPLES; TIME DEPENDENT; TWEEN 80;

VEHICLES;

EID: 25144469720     PISSN: 09514198     EISSN: None     Source Type: Journal    
DOI: 10.1002/rcm.2102     Document Type: Article

References (23)

1. Roberts SA. Xenobiotica 2001; 31: 557.
2. Tse FLS, Jaffe JM. In Drugs and the Pharmaceutical Sciences, vol. 46, Swarbrick J (ed). Marcel Dekker: New York, 1991; 34.
3. Fort FL, Heyman IA, Kesterson JW. J. Parenter. Sci. Technol. 1984; 38: 82.
4. Korfmacher W. In Using Mass Spectrometry for Drug Metabolism Studies, Korfmacher W (ed). CRC Press: Boca Raton, 2005; 1-34.
5. Korfmacher WA, Cox KA, Bryant MS, Veals J, Ng K, Lin CC. Drug. Discov. Today 1997; 2: 532.
6. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Mass Spectrom. Rev. 1990; 9: 37.
7. Bruins AP. J. Chromatogr. A 1998; 794: 345.
8. Thomson BA, Danylewychmay L, Henion JD. J. Am. Chem. Soc. 1983; 186: 19.
9. Mei H, Hsieh Y, Nardo C, Xu X, Wang S, Ng K, Korfmacher WA. Rapid Commun. Mass Spectrom. 2003; 17: 97.
10. Korfmacher WA, Cox KA, Ng KJ, Veals J, Hsieh Y, Wainhaus S, Broske L, Prelusky D, Nomeir A, White RE. Rapid Commun. Mass Spectrom. 2001; 15: 335.
11. King R, Bonfiglio R, Fernandez-Metzler C, Miller-Stein C, Olah T. J. Am. Soc. Mass Spectrom. 2000; 11: 942.
12. Miller-Stein C, Bonfiglio R, Olah TV, King RC. Am. Pharm. Rev. 2000; 3: 54.
13. Tiller PR, Romanyshyn LA. Rapid Commun. Mass Spectrom. 2002; 16: 92.
14. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Anal. Chem. 1998; 70: 882.
15. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Anal. Chem. 2003; 75: 3019.
16. Shou WZ, Naidong W. Rapid Commun. Mass Spectrom. 2003; 17: 589.
17. Xu X, Veals J, Korfmacher WA. Rapid Commun. Mass Spectrom. 2003; 17: 832.
18. Tong XS, Wang J, Zheng S, Pivnichny JV, Griffin PR, Shen X, Donnelly M, Vakerich K, Nunes C, Fenyk-Melody J. Anal. Chem. 2002; 74: 6305.
19. Iribarne JV, Dziedzic P, Thomson BA. Int. J. Mass Spectrom. Ion Phys. 1983; 50: 331.
20. Tang L, Kebarle P. Anal. Chem. 1993; 65: 3654.
21. Tang L, Kebarle P. Anal. Chem. 1991; 63: 2709.
22. Enke CG. Anal. Chem. 1997; 69: 4885.
23. Mei H. In Using Mass Spectrometry for Drug Metabolism Studies, Korfmacher W (ed). CRC Press: Boca Raton, 2005; 103-150.